β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial

Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management

(2015) Gianluca Campo et al.   CARDIOVASCULAR DRUGS AND THERAPY

Platelet function testing to adjust antiplatelet therapy for elective coronary stenting: a landmark analysis of the ARCTIC trial

(2014) G. Montalescot et al.   EUROPEAN HEART JOURNAL

Is the panic about beta-blockers in perioperative care justified?

(2014) T. F. Luscher et al.   EUROPEAN HEART JOURNAL

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management

(2014)   EUROPEAN HEART JOURNAL

Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes

(2014) Chris P. H. Lexis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Beta-Blocker Therapy and Cardiac Events Among Patients With Newly Diagnosed Coronary Heart Disease

(2014) Charlotte Andersson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure

(2014) Kim Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preoperative β-Blocker Use in Coronary Artery Bypass Grafting Surgery

(2014) William Brinkman et al.   JAMA Internal Medicine

Long Term Effects of Epoetin Alfa in Patients with ST- Elevation Myocardial Infarction

(2013) Marieke L. Fokkema et al.   CARDIOVASCULAR DRUGS AND THERAPY

Gastroprotection in Low-Dose Aspirin Users for Primary and Secondary Prevention of ACS: Results of a Cost-Effectiveness Analysis Including Compliance

(2013) N. L. de Groot et al.   CARDIOVASCULAR DRUGS AND THERAPY

Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery

(2013) Sonia Bouri et al.   HEART

Association of β-Blocker Therapy With Risks of Adverse Cardiovascular Events and Deaths in Patients With Ischemic Heart Disease Undergoing Noncardiac Surgery

(2013) Charlotte Andersson et al.   JAMA Internal Medicine

RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials

(2012) Thomas G. von Lueder et al.   CARDIOVASCULAR DRUGS AND THERAPY

Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus

(2012) Venkatesh L. Murthy et al.   CIRCULATION

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease

(2012) Sripal Bangalore et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

(2012) Stephan D. Fihn et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sustained postoperative anaemia is associated with an impaired outcome after coronary artery bypass graft surgery: insights from the IMAGINE trial

(2011) B. D. Westenbrink et al.   HEART

Lack of Effect of Oral Beta-Blocker Therapy at Discharge on Long-Term Clinical Outcomes of ST-Segment Elevation Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention

(2010) Neiko Ozasa et al.   AMERICAN JOURNAL OF CARDIOLOGY

Effects of Angiotensin-Converting Enzyme Inhibition in Low-Risk Patients Early After Coronary Artery Bypass Surgery

(2007) Jean L. Rouleau et al.   CIRCULATION